in-PharmaTechnologist RSS

Round-up of new pharmaceutical manufacturing facilities

Natalie.MORRISON@wrbm.com (Natalie MORRISON) — Wed, 16 May 2012 11:55:51 +0200

in-PharmaTechnologist.com presents the latest new facilities to spring up all over the world, including a plasma-based therapy expansion for Baxter, a North African foray for Julphar, and a supply chain step-up for Vetter.

USP and BPC harmonize first finished product monographs

Gareth.MACDONALD@wrbm.com (Gareth MACDONALD) — Wed, 16 May 2012 11:36:12 +0200

Drug manufacturers will benefit from harmonisation of finished product monographs says the USP after a first of its kind collaboration with the BPC.

Dendreon to slash costs using production automation; CFO

Nick.TAYLOR@wrbm.com (Nick TAYLOR) — Wed, 16 May 2012 11:12:16 +0200

Dendreon hopes to cut its cost of goods sold by two-thirds through automation of tasks at its cancer vaccine plants.

Flamma adds commercial scale abilities for gas

Natalie.MORRISON@wrbm.com (Natalie MORRISON) — Tue, 15 May 2012 11:50:09 +0200

Flamma Italy has expanded its gas production capabilities after buying a facility near Milan, Italy.

PTI stresses benefits of non-destructive testing at Interphex

Gareth.MACDONALD@wrbm.com (Gareth MACDONALD) — Tue, 15 May 2012 10:06:15 +0200

PTI says its new non-destructive testing technology is uniquely positioned to help manufacturers reduce waste and save time and money.

Generic Lipitor drives jump in pharma revenues at Codexis

Nick.TAYLOR@wrbm.com (Nick TAYLOR) — Tue, 15 May 2012 12:02:17 +0200

Codexis posted a jump in pharma sales after the Lipitor patent loss drove an uptick in demand for its atorvastatin intermediate.

Orchid net profit tumbles as traumatic 2012 ends on a low

Nick.TAYLOR@wrbm.com (Nick TAYLOR) — Tue, 15 May 2012 10:45:19 +0200

Fourth quarter net profit at Orchid fell by two-thirds as the Indian API manufacturer ended a difficult year on a low.

DSM says bids for maleic anhydride biz were too low

Gareth.MACDONALD@wrbm.com (Gareth MACDONALD) — Mon, 14 May 2012 16:30:08 +0200

DSM ended a five year search for a buyer for its maleic anhydride derivatives business last week after bids failed to meet expectations.

FDA relaxes sterility test requirement for biologics

Gareth.MACDONALD@wrbm.com (Gareth MACDONALD) — Mon, 14 May 2012 11:58:12 +0200

The US FDA has changed its sterility testing requirements for biological products to give manufacturers greater flexibility and encourage use of ‘state-of-the-art’ analysis methods.

People on the move: jobs in pharma

Natalie.MORRISON@wrbm.com (Natalie MORRISON) — Mon, 14 May 2012 11:29:26 +0200

in-PharmaTechnologist presents the latest job moves in the pharmaceutical industry including news from Incline, Tonix, and ABPI.

ICH sends Q11 guidelines to EU, US & Japanese regulators

Nick.TAYLOR@wrbm.com (Nick TAYLOR) — Mon, 14 May 2012 10:56:17 +0200

The ICH has sent its Q11 guidelines on APIs to regulatory bodies in the US, European Union and Japan for adoption.

in-Pharmatechnologist.com's review of Interphex 2012

Gareth.MACDONALD@wrbm.com (Gareth MACDONALD) — Thu, 10 May 2012 13:13:20 +0200

in-Pharmatechnologist.com was at Interphex 2012 in New York, US to launch the revamped version of our website and speak to the pharmaceutical manufacturing and processing tech sector’s movers and shakers.

Fette's 'common sense' approach to boosting production

Natalie.MORRISON@wrbm.com (Natalie MORRISON) — Thu, 10 May 2012 12:53:12 +0200

Reduce changeover time on oral solid dose machinery by cleaning equipment offline, Fette Compacting urged drugsmakers at this year’s Interphex.

People on the move: jobs in pharma

Natalie.MORRISON@wrbm.com (Natalie MORRISON) — Thu, 10 May 2012 11:01:17 +0200

in-Pharmatechnologist brings you the lowdown of the latest new faces within the pharmaceutical industry, including news from Novo Nordisk, Generix, and Watson Pharma.

AMPAC Fine Chemicals posts loss despite anti-viral surge

Nick.TAYLOR@wrbm.com (Nick TAYLOR) — Thu, 10 May 2012 11:08:48 +0200

The return of antiviral sales helped AMPAC Fine Chemicals grow sales in the second quarter but it still posted an operating loss.

Effective controls still lacking for continuous processing says Interphex panel

Gareth.MACDONALD@wrbm.com (Gareth MACDONALD) — Wed, 09 May 2012 13:13:12 +0200

Continuous processing is still hamstrung by a lack of control systems and is not ready for specific FDA guidance according to an industry expert panel which met at Interphex last week.

BASF buys omega-3 maker Equateq citing pharma potential

Gareth.MACDONALD@wrbm.com (Gareth MACDONALD) — Wed, 09 May 2012 11:23:11 +0200

BASF has bought omega-3 fatty acid maker Equateq, citing its pharmaceutical and dietary supplements businesses as key beneficiaries.

New dry powder inhaler will improve delivery, says Aptar

Natalie.MORRISON@wrbm.com (Natalie MORRISON) — Wed, 09 May 2012 12:50:01 +0200

Aptar Pharma has launched a new twistable dry powder inhaler (DPI) which it says is a “cost effective” way to improve drug delivery as well as patient compliance.

Indian minister rails against anti-generics smear campaign

Nick.TAYLOR@wrbm.com (Nick TAYLOR) — Wed, 09 May 2012 12:24:22 +0200

The Indian government says multinational companies are running “a concerted campaign” against its generics industry.

Single-use is the future of biomanufacturing: report from Interphex

Natalie.MORRISON@wrbm.com (Natalie MORRISON) — Mon, 07 May 2012 12:44:17 +0200

Advancements in single-use equipment are crucial to the development of the biotechnology industry, according to experts at this year’s Interphex.